MUVON Therapeutics announced that Dr Christine Günther, MD, PhD, has been appointed Chief Technology Officer (CTO), effective December 1, 2025, as the clinical-stage biotech advances its regenerative medicine platform for skeletal muscle tissue repair. The company said her addition will…
Browsing: All news
Category Added in a WPeMatico Campaign
Telomir Pharmaceuticals said that its lead therap
Life Time has opened a new adults-only fitness an
Regenerative medicine firm says new capital give
FDA clears ENV-308 for Phase 1 as Enveda doses f
Funding accelerates clinical rollout of glycan b
From insulin to GLP-1s, peptide therapies harnes
Urolithin A may support healthier immune aging.
PeptiDream and Alnylam Pharmaceuticals announced
Alnylam Pharmaceuticals said it will invest about